Back to Search
GHASSAN K ABOU-ALFA MD
MD
Medical Oncology Physician
NPI: 1134190168IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
220887(NY)
Education
OTHER
Class of 1992
Research & Publications (20)
Commentary: Sorafenib -- the end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning?
PMID 19144679·Oncologist·2009
8-other
Selection of patients with hepatocellular carcinoma for sorafenib.
PMID 19406040·J Natl Compr Canc Netw·2009
6-review
The impact of new data in the treatment of advanced hepatocellular carcinoma.
PMID 18765149·Curr Oncol Rep·2008
6-review
Current management of advanced hepatocellular carcinoma.
PMID 19259298·Gastrointest Cancer Res·2008
8-other
Treatment of hepatocellular carcinoma: considerations regarding etiology and molecular biology.
PMID 19360155·Gastrointest Cancer Res·2007
8-other
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
PMID 16983112·J Clin Oncol·2006
3-trial
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.
PMID 16062073·Am J Clin Oncol·2005
3-trial
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.
PMID 16908937·J Clin Oncol·2006
3-trial
Hepatocellular carcinoma in two patients with cardiac cirrhosis.
PMID 19550346·Eur J Gastroenterol Hepatol·2010
5-case
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
PMID 19255312·J Clin Oncol·2009
3-trial
Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers.
PMID 19306817·Surg Oncol Clin N Am·2009
6-review
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy.
PMID 18236117·Ann Surg Oncol·2008
6-review
Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer.
PMID 18446142·Nat Clin Pract Oncol·2008
8-other
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
PMID 18580211·Ann Surg·2008
8-other
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
PMID 18802958·J Surg Oncol·2008
8-other
Expanding the treatment options for hepatocellular carcinoma: combining transarterial chemoembolization with radiofrequency ablation.
PMID 18398085·JAMA·2008
8-other
Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice.
PMID 17697101·J Am Geriatr Soc·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1134190168
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile